Association of increased interferon-inducible gene expression with disease activity in patients with lupus nephritis
10.3760/cma.j.issn.1007-7480.2009.01.008
- VernacularTitle:狼疮肾炎患者Ⅰ型干扰素诱导基因表达的研究
- Author:
Guimei GUO
;
Shunle CHEN
;
Nan SHEN
;
Min DAI
;
Xuming NI
;
Jie QIAN
- Publication Type:Journal Article
- Keywords:
Lupus nephritis;
Interferon type Ⅰ;
Real-time polymerase chain reaction
- From:
Chinese Journal of Rheumatology
2009;13(1):8-11
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study 6 type Ⅰ interferon (IFN)-inducible genes (IFIT4, IFI44, Ly6e,OAS1, OAS2 and OAS3) in patients with lupus nephritis (LN) and analyze its correlated expression levels with disease activity and/or clinical manifestations. Methods Total RNA was obtained simultaneously from kidney tissues and peripheral blood cells of 12 patients with diffuse proliferative lupus nephritis and 10 normal controls. Moreover, peripheral blood cells were obtained from 119 LN patients and 35 normal controls. Total RNA was extracted and reversely transcribed into complementary DNA. Gene expression levels were measured by real-time polymerase chain reaction by comparing to a housekeeping gene, and IFN score was calculated. Disease activity was determined by the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI). Results The 6 genes were highly expressed in diffuse proliferative lupus nephritis patients compared with normal controls. IFN scores were positively correlated with SLEDAI score, the concurrent presences of anti-double-stranded DNA (anti-dsDNA) antibodies (P<0.05) and hypocomplementemia (P<0.01). Conclusion The 6 IFN-inducible genes are highly expressed iri LN patients. IFN scores are elevated in active lupus nephritis patients, in patients with positive anti-ds-DNA antibody and hypocomplementemia. IFN scores may be a useful biomarker for lupus nephritis therapy.
